(Q36605779)

English

An adaptive, dose-finding, seamless phase 2/3 study of a long-acting glucagon-like peptide-1 analog (dulaglutide): trial design and baseline characteristics

scientific article published on November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

An adaptive, dose-finding, seamless phase 2/3 study of a long-acting glucagon-like peptide-1 analog (dulaglutide): trial design and baseline characteristics (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

phase II clinical trial

0 references

phase III clinical trial

0 references

author name string

Mary Jane Geiger

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Zachary Skrivanek

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Brenda Gaydos

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jenny Chien

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Scott Berry

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Donald Berry

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

1 November 2012

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Journal of Diabetes Science and Technology

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1319-1327

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Operational challenges and solutions with implementation of an adaptive seamless phase 2/3 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

30 September 2017

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

30 September 2017

Exenatide: a review from pharmacology to clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

30 September 2017

Resting heart rate in cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

30 September 2017

High heart rate: a cardiovascular risk factor?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

30 September 2017

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

30 September 2017

Application of adaptive design methodology in development of a long-acting glucagon-like peptide-1 analog (dulaglutide): statistical design and simulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

20 September 2018

Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

20 September 2018

A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

20 September 2018

Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

20 September 2018

Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

20 September 2018

Pharmacokinetics, pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570871

20 September 2018

Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

1 reference

https://api.crossref.org/works/10.1177%2F193229681200600610

21 January 2018

Practical modifications of the continual reassessment method for phase I cancer clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/23294776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23294776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a long-acting GLP-1 mimetic (PF-04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23294776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LY2189265, a long-acting glucagon-like peptide-1 analogue, showed a dose-dependent effect on insulin secretion in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/23294776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets

1 reference

https://pubmed.ncbi.nlm.nih.gov/23294776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/193229681200600610

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36605779&oldid=1640435308"